These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects. Israel KS; Black HR; Brier GL; Wolny JD; DeSante KA Antimicrob Agents Chemother; 1982 Jul; 22(1):94-102. PubMed ID: 6214998 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of moxalactam in patients with normal and impaired renal function. Aronoff GR; Sloan RS; Luft FC J Infect Dis; 1982 Mar; 145(3):365-9. PubMed ID: 6460824 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of moxalactam in adults]. Humbert G; Leroy A; Fillastre JP Sem Hop; 1983 Jun; 59(26):1963-7. PubMed ID: 6310787 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and clinical evaluation of moxalactam in infants and children. Latif R; Thirumoorthi MC; Buckley JA; Kobos DM; Aravind MK; Kauffman RE; Dajani AS Dev Pharmacol Ther; 1981; 3(4):222-31. PubMed ID: 6212231 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers. Srinivasan S; Fu KP; Neu HC Antimicrob Agents Chemother; 1981 Feb; 19(2):302-5. PubMed ID: 6214989 [TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers. Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of moxalactam in patients with renal insufficiency. Lam M; Manion CV; Czerwinski AW Antimicrob Agents Chemother; 1981 Mar; 19(3):461-4. PubMed ID: 6454383 [TBL] [Abstract][Full Text] [Related]
15. [The penetration of moxalactam into bone (author's transl)]. Wittmann DH; Schassan HH; Kohler F; Seidel H Unfallchirurgie; 1981; 7(3):142-6. PubMed ID: 6455002 [TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam. Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213 [TBL] [Abstract][Full Text] [Related]
17. Moxalactam kinetics during chronic ambulatory peritoneal dialysis. Singlas E; Boutron HF; Merdjan H; Brocard JF; Pocheville M; Fries D Clin Pharmacol Ther; 1983 Sep; 34(3):403-7. PubMed ID: 6224624 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. Bolton WK; Scheld WM; Spyker DA; Overby TL; Sande MA Antimicrob Agents Chemother; 1980 Dec; 18(6):933-8. PubMed ID: 6453555 [TBL] [Abstract][Full Text] [Related]
19. Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels. Wise R; Baker S; Livingston R Antimicrob Agents Chemother; 1980 Sep; 18(3):369-71. PubMed ID: 6252833 [TBL] [Abstract][Full Text] [Related]
20. [Comparative pharmacokinetics of moxalactam and other cephalosporins]. Fourtillan JB; Brisson AM Sem Hop; 1983 Jun; 59(26):1968-71. PubMed ID: 6310788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]